Umbilical Cord blood Native Nuecleated cells (UCB-NNC)

Human cord blood native nucleated cells (HCBNNCs) are separated from umbilical cord blood using a proprietary protocol. HCBNNCs are screened for the expression of immune marker CD45 and their viability is assessed using Acridine Orange or DAPI staining and our state of the art fully automated cell counting machine. This highly purified population of cells makes it possible to further isolate specific and more rare populations, as well as additional downstream processes.

The Altogex™ fraction is a result of a validated technology composed of lymphocytes (T cells, B cells, and natural killer cells), monocytes, dendritic cells, and stem/progenitor cells. These cells are important cellular components of the immune system and essential in effective humoral and cell-mediated immune responses. These cells are commonly used in basic science research as well as IND (Investigational New Drug)-approved clinical applications in the fields of immunology and infectious disease. The long-term goals of many of our customers include vaccine development and cellular transplantation.